Annual report pursuant to Section 13 and 15(d)

TRANSITION PERIOD COMPARATIVE DATA (Tables)

v3.24.0.1
TRANSITION PERIOD COMPARATIVE DATA (Tables)
12 Months Ended
Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]  
Selective Interim Reporting Financial Information
The following table shows selected financial information for the twelve months ended December 31, 2023 and the comparative period ended December 31, 2022 (the “Comparative Period”). The Comparative Period information is derived from the Company’s unaudited, consolidated and combined financial statements.
Twelve Months Ended December 31,
2023 2022
(Unaudited)
Condensed income statement
Total revenues $ 1,297,429  $ 1,209,968 
Total costs and expenses 1,244,955  1,179,397 
Loss on impairment —  (5,187)
Gains (losses) on disposal of assets 1,112  (521)
Earnings from unconsolidated affiliates 7,165  1,136 
Operating income 60,751  25,999 
Total other income (expense), net (42,739) (6,036)
Income tax expense (24,932) (10,754)
Net loss attributable to noncontrolling interests 140 
Net income (loss) attributable to Bristow Group Inc. $ (6,780) $ 9,215 
Earnings (losses) per common share:
Basic $ (0.24) $ 0.33 
Diluted $ (0.24) $ 0.32 
Weighted average shares of common stock outstanding:
Basic 28,139  28,104 
Diluted 28,139  28,406 
Condensed cash flows
Net cash provided by (used in) operating activities $ 32,037  $ (7,727)
Net cash used in investing activities (47,319) (51,984)
Net cash provided by (used in) financing activities 22,035  (24,623)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 13,226  (29,445)
Net increase (decrease) in cash, cash equivalents and restricted cash 19,979  (113,779)
Cash, cash equivalents and restricted cash at beginning of period 163,683  277,462 
Cash, cash equivalents and restricted cash at end of period $ 183,662  $ 163,683 
Condensed balance sheets
Total assets $ 1,937,278  $ 1,812,001 
Total liabilities $ 1,114,099  $ 1,025,062 
Total stockholders’ equity $ 823,179  $ 786,939